Bernie Romanin

Chief Executive Officer and Director

Dr. Robyn A. Lindley

Chief Scientific Officer and Director

Kevin Hollingsworth

Chief Financial Officer

 

FCPA, FCMA, CGMA

Kevin Hollingsworth is Principal of Hollingsworth Financial Services which has provided professional accounting, taxation, business planning and investment strategies to individuals as well as small and medium sized businesses for more than 25 years.

He has extensive knowledge and expertise in taking private companies to listing. He is currently Chief Financial Officer and Company Secretary of Paradigm Biopharmaceuticals Ltd (ASX: PAR). Prior to that he served as Chief Financial Officer and Company Secretary of Mesoblast Limited (ASX: MSB), Patrys Limited (ASX: PAB) and Alpha Technologies Corporation Limited (ASX: ASU).

Kevin Hollingsworth is a Fellow of CPA Australia, a Fellow of Chartered Management Accountants, and a Chartered Global Management Accountant.

He is a past National President of CIMA Australia and a State Councillor for CPA Australia. 

Richard Rendell

CTO & Director

Dr. Nathan Hall

Senior Scientist

Dr. Jared Mamrot

Bioinformatician

LEGAL

© 2020 GMDx Genomics. All rights reserved.